This size prefilled syringe is just being launched, but we’ve heard very optimistic revenue color from Joe and the company since January. When moaning occurred after the company raised capital at a big discount, we heard its a no brainer deal because they’re funding commercialization. Initial batches were sold out. So personally, I’m interested to see the revenue recorded. Something to build upon.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links